Healthy volunteers wanted for first human tests of Brain-Targeting drug
NCT ID NCT07463196
First seen Mar 21, 2026 · Last updated Apr 29, 2026 · Updated 6 times
Summary
This early-stage study tests a new drug called ACI-19764 in 78 healthy adults aged 18-65. The goal is to check its safety, how the body handles it, and its effects on immune markers. Participants receive either the drug or a placebo, once or daily for 14 days. This study does not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ICON
RECRUITINGGroningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.